...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of cosmetic dermatology. >Observation of the clinical efficacy of isotope phosphorus‐32 dressing combined with diprospan and mucopolysaccharide polysulphate cream in the treatment of keloids
【24h】

Observation of the clinical efficacy of isotope phosphorus‐32 dressing combined with diprospan and mucopolysaccharide polysulphate cream in the treatment of keloids

机译：Observation of the clinical efficacy of isotope phosphorus‐32 dressing combined with diprospan and mucopolysaccharide polysulphate cream in the treatment of keloids

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相关主题

摘要

Abstract Objective The present study aims to investigate the effectiveness, recurrence, and adverse reaction rates of isotope phosphorus‐32 dressings combined with diprospan and mucopolysaccharide polysulphate cream in the treatment of keloids. Methods A total of 80 patients with keloids admitted to the Dermatology Clinic of the Fourth Affiliated Hospital of Harbin Medical University between June 2019 and June 2021 were included in the present study and randomly divided into three groups: Control Group 1 (n?=?27), Control Group 2 (n?=?25), and the treatment group (n?=?28). Patients in Control Group 1 were treated with diprospan combined with mucopolysaccharide polysulphate cream, patients in Control Group 2 were treated with an isotopic phosphorus‐32 dressing combined with mucopolysaccharide polysulphate cream, and patients in the treatment group were treated with an isotopic phosphorus‐32 dressing combined with diprospan and mucopolysaccharide polysulphate cream. The effectiveness, recurrence, and adverse reaction rates were observed in all three groups. Results The treatment group had the most significant decrease in the itching scores. The respective effectiveness, recurrence, and adverse reaction rates were 81.4%, 43.6%, and 74.1% in Control Group 1; 56%, 38.7%, and 64% in Control Group 2; and 96.7%, 11.2%, and 41% in the treatment group. The differences were statistically significant (p?

著录项

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号